SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2008-03-26
Filing Date Changed: 2008-03-27
Documents: 6

SEC Accession No.
0000936392-08-000228
Filing date: 2008-03-27
Accepted: 2008-03-27 17:02:16

Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq	Type	Document	Size	Description
1	8-K	a39370e8vk.htm	18767	FORM 8-K
2	EX-1.1	a39370exv1w1.htm	179615	EXHIBIT 1.1
3	EX-5.1	a39370exv5w1.htm	5934	EXHIBIT 5.1
4	EX-10.1	a39370exv10w1.htm	60428	EXHIBIT 10.1
5	EX-10.2	a39370exv10w2.htm	44337	EXHIBIT 10.2
6	GRAPHIC	a39370a3937000.gif	5059	GRAPHIC

		0000936392-08-000228.txt	317991	Complete submission text file

Filer Information:

AVANIR PHARMACEUTICALS (Filer) (0000858803)
IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-15803 | Film No.: 08715712
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656
949-389-6700

Mailing Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656